154 related articles for article (PubMed ID: 21957737)
1. Growth factor and cytokine interactions in myogenesis. Part II. Expression of IGF binding proteins and protein kinases essential for myogenesis in mouse C2C12 myogenic cells exposed to TNF-alpha and IFN-gamma.
Wieteska-Skrzeczyńska W; Grzelkowska-Kowalczyk K; Rejmak E
Pol J Vet Sci; 2011; 14(3):425-31. PubMed ID: 21957737
[TBL] [Abstract][Full Text] [Related]
2. Growth factor and cytokine interactions in myogenesis. Part I. The effect of TNF-alpha and IFN-gamma on IGF-I-dependent differentiation in mouse C2C12 myogenic cells.
Wieteska-Skrzeczyńska W; Grzelkowska-Kowalczyk K; Tokarska J; Grabiec K
Pol J Vet Sci; 2011; 14(3):417-24. PubMed ID: 21957736
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1beta stimulates early myogenesis of mouse C2C12 myoblasts: the impact on myogenic regulatory factors, extracellular matrix components, IGF binding proteins and protein kinases.
Grabiec K; Tokarska J; Milewska M; Błaszczyk M; Gajewska M; Grzelkowska-Kowalczyk K
Pol J Vet Sci; 2013; 16(2):255-64. PubMed ID: 23971193
[TBL] [Abstract][Full Text] [Related]
4. Treatment with TNF-alpha and IFN-gamma alters the activation of SER/THR protein kinases and the metabolic response to IGF-I in mouse c2c12 myogenic cells.
Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
Cell Mol Biol Lett; 2010; 15(1):13-31. PubMed ID: 19685010
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK.
Chen SE; Jin B; Li YP
Am J Physiol Cell Physiol; 2007 May; 292(5):C1660-71. PubMed ID: 17151142
[TBL] [Abstract][Full Text] [Related]
7. Exposure to TNF-alpha but not IL-1beta impairs insulin-dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells.
Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
Pol J Vet Sci; 2006; 9(1):1-10. PubMed ID: 16573269
[TBL] [Abstract][Full Text] [Related]
8. EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines.
Minami M; Koyama T; Wakayama Y; Fukuhara S; Mochizuki N
Mol Biol Cell; 2011 Sep; 22(18):3508-19. PubMed ID: 21795402
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity.
Tolosa L; Morlá M; Iglesias A; Busquets X; Lladó J; Olmos G
Cell Signal; 2005 Nov; 17(11):1333-42. PubMed ID: 16125053
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR; Ewton DZ; Coolican SA
Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
[TBL] [Abstract][Full Text] [Related]
11. Treatment with IFN-gamma prevents insulin-dependent PKB, p70S6k phosphorylation and protein synthesis in mouse C2C12 myogenic cells.
Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
Cell Biol Int; 2009 Dec; 34(1):117-24. PubMed ID: 19947939
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle.
Anwar A; Zahid AA; Scheidegger KJ; Brink M; Delafontaine P
Circulation; 2002 Mar; 105(10):1220-5. PubMed ID: 11889017
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-α alters integrins and metalloprotease ADAM12 levels and signaling in differentiating myoblasts.
Grzelkowska-Kowalczyk K; Tokarska J; Grabiec K; Gajewska M; Milewska M; Błaszczyk M
Pol J Vet Sci; 2016; 19(2):253-9. PubMed ID: 27487498
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
Haugk KL; Wilson HM; Swisshelm K; Quinn LS
Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
[TBL] [Abstract][Full Text] [Related]
15. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.
Sarbassov DD; Jones LG; Peterson CA
Mol Endocrinol; 1997 Dec; 11(13):2038-47. PubMed ID: 9415407
[TBL] [Abstract][Full Text] [Related]
16. Role of the α2 subunit of AMP-activated protein kinase and its nuclear localization in mitochondria and energy metabolism-related gene expressions in C2C12 cells.
Okamoto S; Asgar NF; Yokota S; Saito K; Minokoshi Y
Metabolism; 2019 Jan; 90():52-68. PubMed ID: 30359677
[TBL] [Abstract][Full Text] [Related]
17. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
[TBL] [Abstract][Full Text] [Related]
19. TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway.
Zhao Q; Yang ST; Wang JJ; Zhou J; Xing SS; Shen CC; Wang XX; Yue YX; Song J; Chen M; Wei YY; Zhou QP; Dai T; Song YH
Biochem Biophys Res Commun; 2015 Mar; 458(4):790-5. PubMed ID: 25686491
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
